Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 31.18
+0.18 (0.58%)
Sep 30, 2026, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 12.65 billion as of October 2, 2026. Its market cap has increased by 16.80% in one year.
Market Cap
12.65B
Enterprise Value
12.94B
Revenue
759.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.18
ChartMarket Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 12.65B, a decrease of -21.77%. That is a compound annual growth rate of -4.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 12.65B | 22.88% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 14.35B |
| Shanghai Medicilon | 14.16B |
| Nanjing Vazyme Biotech | 14.08B |
| Jinyu Bio-technology | 12.65B |
| Inner Mongolia Furui Medical Science | 12.44B |
| Hualan Biological Vaccine | 11.97B |
| Mabwell (Shanghai) Bioscience | 11.61B |
| Shanghai OPM Biosciences | 11.32B |